Background
==========

The optimal duration of antibiotic therapy for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) is not clear. A multicentre randomised controlled trial indicated similar clinical efficacy for 8 versus 15 days of antibiotic therapy for VAP, with less emergence of multiresistant organisms following the shorter course \[[@B1]\]. *Pseudomonas aeruginosa*is difficult to eradicate, however, and American Thoracic Society guidelines for treatment of HAP due *to P. aeruginosa*recommend 14 days of therapy \[[@B2]\]. Our aim was to study the rate of recurrence following treatment of Gram-negative HAP in a critically ill population with short-course (typically 5 days) antibiotic therapy.

Materials and methods
=====================

We retrospectively reviewed 50 patients treated consecutively with short-course (typically 5 days) antibiotic therapy for Gram-negative HAP in a UK teaching hospital critical care unit from 2004 to 2007. Pneumonia was defined as semi-quantitative respiratory culture (≥2+) of a single Gram-negative isolate, clinical pulmonary infection score ≥6 and initiation of antibiotic therapy. Recurrence of HAP was defined either as relapse (pure growth of the organism causing the initial infection) or reinfection (due to a different organism). Patients were studied until hospital discharge or death.

Results
=======

Demographic and outcome data are summarised in Table [1](#T1){ref-type="table"}. The commonest causative organisms were *P. aeruginosa*(42%), Enterobacter species (14%) and Klebsiella species (14%). Two patients died before completing the initial course of antibiotics.

###### 

Demographic and outcome data

  ------------------------------------------------------------- --------------------
  Demographic data at initial diagnosis                         
   Median age (range) (years)                                   69.5 (19--84)
   Sex (% male)                                                 78
   Mechanical respiratory support (%)                           78
   Median APACHE II score                                       19
  Outcome of patients surviving initial course of antibiotics   
   Nonresolution (%)                                            2.1
   Recurrence (%)                                               10.4 (all relapse)
   Intensive care unit mortality (%)                            41.7
   Hospital mortality (%)                                       60.4
  ------------------------------------------------------------- --------------------

Conclusion
==========

Treatment of Gram-negative HAP in the critically ill patient with short-course antibiotic therapy is associated with a low rate of recurrence (10.4%). This compares favourably with reported recurrence rates of 18--26% following ≥2 weeks of antibiotic therapy for VAP \[[@B1],[@B3],[@B4]\].
